Affiliation:
1. Department of Cardiology Guy's Hospital London
Abstract
SUMMARYAtrial fibrillation is the commonest clinical arrhythmia, and is associated with significant morbidity and mortality. The treatment of choice is to restore and maintain sinus rhythm. Although certain antiarrhythmic drugs are more effective than placebo in maintaining sinus rhythm, recurrence of atrial fibrillation post cardioversion remains common. The use of antiarrhythmic drugs can be associated with serious adverse effects due to their negative inotropic and proarrhythmic effects. Radiofrequency ablation of the AV junction is a safe and effective palliative treatment option in patients who have failed drug therapy. Ventricular rate control without the need for permanent pacing can be achieved by AV nodal modification using radiofrequency energy. There is also interest in the role of catheter ablation as a possible curative procedure for atrial fibrillation. Atrial pacing can reduce the incidence of atrial fibrillation in certain subgroups of patients. Finally, low energy intracardiac atrial defibrillation has been shown to be feasible in humans.
Reference40 articles.
1. Study of the prevalence of atrial fibrillation in general practice patients over 65 years of age;Hill JD;J Roy Coll Gen Pract,1987
2. Epidemiologic Features of Chronic Atrial Fibrillation
3. Hospitalisation for arrhythmias in the United States; importance of atrial fibrillation (abstract);Bialy D;J Am Coll Cardiol,1992
4. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.
5. On the multiple wavelet hypothesis of atrial fibrillation;Moe GK;Arch Int Pharmacodyn Ther,1962